Companies/EU/549300QKJ78I

LAKEFRONT BIOTHERAPEUTICS NV

Last · XETRA€24.92+0.30 (+1.22%)stale · yahoo · 250h ago

Limited price history since listing (2025-11-03 → 2026-09-02).

Market cap€1.6B65.5M sh
P/E · TTM2.8fwd — · eps 9.02
Beta0.11vs S&P 500
Div yield—annual · TTM
52w range
€22.84€44.47
Volume44session

Issuer

Legal nameLAKEFRONT BIOTHERAPEUTICS NV
HQEurope (EU)
ListingEU 549300QKJ78I
ISINBE0003818359
LEI549300QKJ78IY0IOV655
SectorHealthcare
IndustryBiotechnology & Medical Research
CurrencyEUR
Entity registrylei:549300QKJ78IY0IOV655
Websitelakefrontbio.com
Employees704
AddressGalapagos NV Industriepark Mechelen Noord 2800, Mechelen +32 1 534 29 00
Headline financial metrics
Revenue€1.1B
Operating income€295.0M
Net income€320.9M
Free cash flow€-271.2M
Operating margin26.5%
Net margin28.9%
Return on equity9.9%
Period2025
Loading chart…

Upcoming earnings

1 event
4:30 PM UTC+1
Period
Sep 2026
Est. EPS
—
Est. revenue
29.0M
View financial calendar →

Earnings transcripts

2 recent

Press & signals

3 of 15 recent
  • GlobeNewswire

    Acquisition of Own Shares

  • GlobeNewswire

    Lakefront to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

  • GlobeNewswire

    Acquisition of Own Shares

The rest of this company's wire — with summaries and source links — is part of Pro.

See plans

Documents

FormReporting forFiledFlags
otherGlobal Tax StrategyIR
—2026-04-280
otherLakefront Biotherapeutics NV PFIC Annual Information StatementIR
—2026-04-280
ANNUAL
2025-12-312026-04-070
Showing 3 of 3 filings